text.skipToContent text.skipToNavigation

Avis pour les clients de l’Indonésie uniquement  Voir les détails
Coordonnées du service client :
pim.indonesia.contact.title2
Layanan Pengaduan Konsumen

(Matériel de performance de l’unité commerciale, équipe de soutien aux ventes)

pim.indonesia.contact.address

Gedung AIA Central, Niveau 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonésie

+62 21 2988 8557

[email protected]

Direktorat Jenderal Perlindungan Konsumen dan Tertib Niaga Kementerian Perdagangan Republik Indonesia
0853 1111 1010

Succès ! Votre demande a été envoyée à notre équipe commerciale.

pim.add.to.wishlist.popup.error

  • /_ui/responsive/common/custom/images/default-supplier-banner-1.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-2.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-3.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-4.jpg
  • /_ui/responsive/common/custom/images/default-supplier-banner-5.jpg

ZYDUS CADILA

Zydus Cadila is a leading Indian pharmaceutical company with a global presence. Established in 1952, the company focuses on developing and manufacturing a wide range of healthcare products, including generic drugs, vaccines, and herbal remedies. They prioritize research and development and have received regulatory approvals from major authorities worldwide. Notably, Zydus Cadila has contributed to the fight against COVID-19 with the development of ZyCoV-D, the world's first plasmid DNA-based vaccine. Committed to sustainability and social responsibility, Zydus Cadila operates in over 50 countries, making a significant impact on global healthcare.

 

Galerie des médias

La quantité de produit a été mise à jour.